Standardized Ultrasound-Guided PIV Insertions Improve Outcomes and Reduce Costs
By MedImaging International staff writers Posted on 06 Oct 2022 |

The use of ultrasound raises significant challenges: the presence of both the ultrasound probe and gel on at the sterile insertion site can contribute to contamination. In addition, gel requires difficult clean up, and any gel left on the skin reduces the adherence of the dressing, increasing the chances of dressing failure. Now, a new study has shown that standardizing ultrasound-guided peripheral intravenous (PIV) insertions in a hospital setting using an innovative sterile barrier dressing reduced costs by 73% and staff time for insertions by 50%, while also improving both patient and nursing staff satisfaction.
The study by PICC Excellence (St Hartwell, GA, USA) was done at a medium-sized hospital with 245 beds and an emergency department that sees about 160 patients per day. A five-member vascular access team manages about 90 ultrasound-guided insertions per month. As part of a quality improvement initiative, researchers evaluated existing procedures for ultrasound-guided PIV insertions. They found significant procedural and supply variations among the departments. While the hospital did consistently use a Central Line Dressing Kit for each insertion, researchers observed that inserters wasted some of the more expensive components of the Kit. In addition, patients reported dissatisfaction because some insertions required multiple attempts.
To test possible solutions to these problems, the hospital switched to a standardized approach using an intravenous Start Kit with a sterile barrier ultrasound dressing called UltraDrape from Parker Laboratories Inc. (Fairfield, NJ, USA). In the standardized procedure, inserters first mark the selected site and apply the folded UltraDrape dressing to the skin. The ultrasound gel is applied to the back side of the dressing for ultrasound probe position and guidance during the insertion. Finally, the gel layer of the dressing is lifted off, and the dressing pulled down over the catheter, creating a sterile transparent dressing cover.
When the hospital switched to the standardized procedure, the data collected demonstrated impressive results. The average cost of supplies per insertion dropped from USD 25.32 to USD 6.71, which would add up to savings of more than USD 20,000 per year. In addition, the time required for each insertion was reduced from 6.51-12.14 minutes to just 3.2-4.25 minutes. Moreover, both patients and staff reported being far happier because of quicker insertions and fewer failed attempts. UltraDrape is simple to use, cost effective and faster than using standard probe covers. Using ultrasound to guide PIV insertions also improves the success rate for insertions, especially for patients with more co-morbidities requiring special skill with visualization technology.
“Our study shows that it is possible to improve outcomes and procedures for ultrasound-guided PIV insertions while also significantly cutting costs and staff time and reducing waste,” said Dr. Nancy Moureau, CEO of PICC Excellence and an internationally recognized expert and consultant in vascular access. “These results suggest that hospitals should consider more widespread use of the standardized UltraDrape dressing procedure.”
“It is the only dressing that separates the gel from the insertion site and that removes the gel after insertion, while providing sterile probe protection,” added Moureau. “For the estimated 12 million ultrasound-guided PIV insertions done each year in North America, it offers a win-win solution, simplifying and speeding up the procedure while reducing costs and time.”
“The UltraDrape dressing enables a level of standardization that simplifies the procedure while ensuring that sterile conditions are maintained,” said co-author Pam Pressnall. “This helped us achieve a level of efficiency that allows us to perform more ultrasound-guided patient insertions in fewer attempts, resulting in happier patients and nursing staff.”
Related Links:
PICC Excellence
Parker Laboratories Inc.
Latest Ultrasound News
- AI Identifies Heart Valve Disease from Common Imaging Test
- Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
- Ultrasound-Based Microscopy Technique to Help Diagnose Small Vessel Diseases
- Smart Ultrasound-Activated Immune Cells Destroy Cancer Cells for Extended Periods
- Tiny Magnetic Robot Takes 3D Scans from Deep Within Body
- High Resolution Ultrasound Speeds Up Prostate Cancer Diagnosis
- World's First Wireless, Handheld, Whole-Body Ultrasound with Single PZT Transducer Makes Imaging More Accessible
- Artificial Intelligence Detects Undiagnosed Liver Disease from Echocardiograms
- Ultrasound Imaging Non-Invasively Tracks Tumor Response to Radiation and Immunotherapy
- AI Improves Detection of Congenital Heart Defects on Routine Prenatal Ultrasounds
- AI Diagnoses Lung Diseases from Ultrasound Videos with 96.57% Accuracy
- New Contrast Agent for Ultrasound Imaging Ensures Affordable and Safer Medical Diagnostics
- Ultrasound-Directed Microbubbles Boost Immune Response Against Tumors
- POC Ultrasound Enhances Early Pregnancy Care and Cuts Emergency Visits
- AI-Based Models Outperform Human Experts at Identifying Ovarian Cancer in Ultrasound Images
- Automated Breast Ultrasound Provides Alternative to Mammography in Low-Resource Settings
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more